The COVID-19 Vaccine to Be Packaged in Mexico Could Be 90% Effective, According to AstraZeneca

This vaccine requires an initial half-dose followed by a full one a month later.
The COVID-19 Vaccine to Be Packaged in Mexico Could Be 90% Effective, According to AstraZeneca
Image credit: Depositphotos.com

Entrepreneur's New Year’s Guide

Let the business resources in our guide inspire you and help you achieve your goals in 2021.
Entrepreneur Staff
2 min read
This article was translated from our Spanish edition using AI technologies. Errors may exist due to this process.
  • This vaccine will be packaged in Mexico after an alliance between AstraZeneca, the University of Oxford and the Carlos Slim Foundation was reported in August.
  • Although in preliminary tests the vaccine prevented 70.4% of the volunteers from getting sick, its effectiveness increased to 90% when using half a dose followed by a full one a month later.

In the race for vaccines against COVID-19, the different pharmaceutical companies have already begun to announce the effectiveness of their respective products. Now it was the turn of AstraZeneca , a company that reported that its vaccine, developed in conjunction with the University of Oxford , is 70.4% effective.

Although in preliminary tests the vaccine prevented 70.4% of the volunteers from getting sick, its effectiveness increased to 90% when using half a dose followed by a full one a month later.

This vaccine will be packaged in Mexico, after an alliance between AstraZeneca, the University of Oxford and the Carlos Slim Foundation was reported in August with the aim of manufacturing, packaging and distributing the vaccine against COVID-19 in the Latin American region to except for Brazil.

Image: Depositphotos.com / NurPhoto | Getty Images / Reuters via BI

This is how AstraZeneca and Oxford join the pharmaceutical companies that have announced the achievement of preventing COVID-19 in the final stage of clinical research. Pfizer in conjunction with BioNTech , and on the other hand, Moderna reported the effectiveness of their vaccines, which proved to be 90% and 94.5% effective, respectively.

More from Entrepreneur

Get heaping discounts to books you love delivered straight to your inbox. We’ll feature a different book each week and share exclusive deals you won’t find anywhere else.
Amplify your business knowledge and reach your full entrepreneurial potential with Entrepreneur Insider’s exclusive benefits. For just $5 per month, get access to premium content, webinars, an ad-free experience, and more! Plus, enjoy a FREE 1-year Entrepreneur magazine subscription.
Create your business plan in half the time with twice the impact using Entrepreneur's BIZ PLANNING PLUS powered by LivePlan. Try risk free for 60 days.

Latest on Entrepreneur